MRGPRX2 on mast cells (MCs) is the target that directly mediates MC activation through the activity of small molecular substances. Previous work has attempted to prove that
substance P (SP) and
PAMP(9-20) induce an MRGPRX2-mediated MC degranulation reaction. However, SP activates MRGPRX2-induced histamine release, which may lead to allergic airway
inflammation, while PAMP(9-20)-induced MrgprB2 activation releases more
tryptase and fewer monoamines. Due to the lack of direct available comparisons, the different types of sensitizing mediators released by the action of SP and
PAMP(9-20) inducing pseudo-
allergic reactions via MRGPRX2 are unclear. To investigate whether the action sites of excited MRGPRX2 are different for SP and
PAMP(9-20), leading to different effects, the release of inflammatory mediators was measured using MC degranulation reactions and
RNA-seq assay in vitro. Mice were treated to observe local
inflammation and MC degranulation in vivo. Moreover, site-directed mutagenesis was used to verify the excited sites of SP and
PAMP(9-20). SP and
PAMP(9-20) both activated MRGPRX2 and led MCs to release inflammatory mediators. Significantly different levels of
histamine,
tryptase, TNF-α, MCP-1, and other
cytokines were released in vivo and in vitro. G165E, D184N, W243R, and H259Y were necessary for SP to activate MRGPRX2, while only D184N and W243R were important for
PAMP(9-20). The downstream signaling pathways activated by SP and
PAMP(9-20) also differed in the phosphorylation level of PKC. There were differences in the sites via which SP and
PAMP(9-20) activate MRGPRX2 and also in the activated downstream signaling pathways, which led to the differences the activation of the pathways and effects of SP- and PAMP(9-20)-induced MRGPRX2 activation.